Researchers have given science a new and unprecedented 3-D view of one of the most important receptors in the brain -- a receptor that allows us to learn and remember, and whose dysfunction is involved in a wide range of neurological diseases and conditions, including Alzheimer's, Parkinson's, schizophrenia and depression. More...
Monday, June 30, 2014
Thursday, June 26, 2014
Researchers find portable, low-cost optical imaging tool useful in concussion evaluation
The findings from the optical-imaging research, employing functional near infrared spectroscopy (fNIRS), provided preliminary support for the tool as a low-cost, portable device for imaging sports and military concussions, researchers said. More...
Posted by D. Shahwan at 9:03:00 AM
Monday, June 16, 2014
Findings point toward one of first therapies for Lou Gehrig's disease
Researchers have determined that a copper compound known for decades may form the basis for a therapy for amyotrophic lateral sclerosis (ALS), or Lou Gehrig's disease. In humans, prior to this, no therapy for ALS has ever been discovered that could extend lifespan more than a few additional months. More...
Posted by D. Shahwan at 8:31:00 AM
Tuesday, June 10, 2014
Statin use associated with less physical activity
Statins in older men is associated with less physical activity, a significant issue for a population that's already sedentary, concludes one of the longest studies of its type. More...
Posted by D. Shahwan at 9:54:00 AM
Tuesday, June 3, 2014
Anti-diabetic drug slows aging and lengthens lifespan, animal study suggests
Researchers have provided new evidence that metformin, the world’s most widely used anti-diabetic drug, slows aging and increases lifespan. More...
Posted by D. Shahwan at 10:35:00 AM